Literature DB >> 3406049

Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence.

K Maarbjerg1, J Aagaard, P Vestergaard.   

Abstract

Of a group of 133 patients given long-term prophylactic lithium treatment, approximately 25 percent discontinued the treatment prematurely within the first six months. Young male patients dominated in the nonadherent group. Clinically the nonadherent patients were characterized by having had an early onset of the illness, a large number of previous hospital admissions and a recent allocation to the diagnostic category of affective disorder. Furthermore, the presence of personality disorders and substance abuses characterized the nonadherent patients. Diagnostic grouping according to polarity did not allow for any distinction between the adherent and nonadherent patients. One half of the nonadherent patients mentioned the development of somatic side effects as their main reason for discontinuing the treatment. Psychological discomfort, such as development of concentration difficulties or impaired memory, was not stated as a reasons for discontinuation. One fourth of the nonadherent patients had their diagnoses, and consequently their treatment, changed by the physician in charge and one fourth neglected instructions and disregarded appointments.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3406049     DOI: 10.1055/s-2007-1014662

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  14 in total

1.  Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder.

Authors:  Louisa G Sylvia; Noreen A Reilly-Harrington; Andrew C Leon; Christine I Kansky; Terence A Ketter; Joseph R Calabrese; Michael E Thase; Charles L Bowden; Edward S Friedman; Michael J Ostacher; Dan V Iosifescu; Joanne Severe; Michelle Keyes; Andrew A Nierenberg
Journal:  Clin Trials       Date:  2011-11-10       Impact factor: 2.486

Review 2.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review.

Authors:  Jennifer B Levin; Anna Krivenko; Molly Howland; Rebecca Schlachet; Martha Sajatovic
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 3.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

Review 4.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

5.  Long-term outcome of lithium prophylaxis in patients initially classified as complete responders.

Authors:  M Maj; R Pirozzi; D Kemali
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder.

Authors:  Martha Sajatovic; Jennifer Levin; Curtis Tatsuoka; Weronika Micula-Gondek; Edna Fuentes-Casiano; Christopher S Bialko; Kristin A Cassidy
Journal:  Bipolar Disord       Date:  2012-05       Impact factor: 6.744

Review 7.  Lithium. Current status in psychiatric disorders.

Authors:  M Peet; J P Pratt
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

Review 8.  The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Authors:  S C Dilsaver; A C Swann; A M Shoaib; T C Bowers
Journal:  J Psychiatry Neurosci       Date:  1993-03       Impact factor: 6.186

9.  Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder.

Authors:  Ching-Wen Chang; Martha Sajatovic; Curtis Tatsuoka
Journal:  Bipolar Disord       Date:  2014-06-26       Impact factor: 6.744

10.  Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study.

Authors:  Jong-Hyun Jeong; Won-Myong Bahk; Young Sup Woo; Ho-Jun Seo; Seung-Chul Hong; Duk-In Jon; Kyung Joon Min; Bo-Hyun Yoon
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.